Status:
COMPLETED
An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension
Lead Sponsor:
Chakshu Research, Inc.
Conditions:
Ocular Hypertension
Eligibility:
All Genders
50-90 years
Phase:
NA
Brief Summary
The purpose of this study is to determine the safety and tolerability of topical C-KAD Ophthalmic Solution in reducing intraocular pressure in patients with ocular hypertension.
Eligibility Criteria
Inclusion
- Both eyes having intraocular pressure in the range of 22-30 mmHg at baseline
- Both eyes having best corrected visual acuity better than 20/50
Exclusion
- Advanced glaucoma
- Closed or barely open anterior chamber or history of angle closure
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2009
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00825396
Start Date
April 1 2007
End Date
April 1 2009
Last Update
June 11 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charlotte Eye, Ear, Nose & Throat Associates
Charlotte, North Carolina, United States, 28210